Alveolar clearance tissue

With distal progression, the protective liquid lining diminishes and clearance rates slow down. Soluble compounds as well as some poorly soluble ultrafine particles may cross the air-liquid interface to enter the tissues and the blood especially in the alveolar region. Depending on the solubility of the particle retention may take years. Alveolar clearance is not a linear process and half live increases with the elimination time. 

PBPK models have also been used to explain the rate of excretion of inhaled trichloroethylene and its major metabolites (Bogen 1988 Fisher et al. 1989, 1990, 1991 Ikeda et al. 1972 Ramsey and Anderson 1984 Sato et al. 1977). One model was based on the results of trichloroethylene inhalation studies using volunteers who inhaled 100 ppm trichloroethylene for 4 horns (Sato et al. 1977). The model used first-order kinetics to describe the major metabolic pathways for trichloroethylene in vessel-rich tissues (brain, liver, kidney), low perfused muscle tissue, and poorly perfused fat tissue and assumed that the compartments were at equilibrium. A value of 104 L/hour for whole-body metabolic clearance of trichloroethylene was predicted. Another PBPK model was developed to fit human metabolism data to urinary metabolites measured in chronically exposed workers (Bogen 1988). This model assumed that pulmonary uptake is continuous, so that the alveolar concentration is in equilibrium with that in the blood and all tissue compartments, and was an expansion of a model developed to predict the behavior of styrene (another volatile organic compound) in four tissue groups (Ramsey and Andersen 1984). 

The pulmonary lymphatic system contributes to the clearance of fluid and protein from the lung tissue interstitium and helps to prevent fluid accumulation in the lungs [108], The lymphatic endothelium allows micron-sized particles (e.g. lipoproteins, plasma proteins, bacteria and immune cells) to pass freely into the lymph fluid [103], After administration of aerosolised ultrafine particles into rats, particles were found in the alveolar walls and in pulmonary lymph nodes [135], which suggests that drainage into the lymph may contribute to the air-to-blood transport of the inhaled particles. 

When a person is exposed to a volatile organic solvent through inhalation, the solvent vapor diffuses very rapidly torough the alveolar membranes, fire connective tissues and the capillary endothelium and into fire red blood cells or plasma. With respiratory gases the whole process takes less than 0.3 seconds. This results in almost instantaneous equilibration between the concentration in alveolar air and in blood and, flierefore, the ratio of the solvent concentration in pulmonary blood to that in alveolar air should be approximately equal to the partition coefficient. As the exposure continues, the solvent concentration in the arterial blood exceeds that in the mixed venous blood. The partial pressures in alveolar air, arterial blood, venous blood and body tissues reach equilibrium at steady state. When the exposure stops, any unmetabolized solvent vapors are removed from the systemic circulation through pulmonary clearance. During that period the concentration in fire arterial blood is lower than in the mixed venous blood and the solvent concentration in alveolar air will depend on the pulmonary ventilation, the blood flow, the solubifity in blood and the concentration in the... 

Intake of lead via inhalation is dependent on atmospheric concentration, peu ticulate size and solubility in tissue fluids. Approximately 30% of inhaled lead is retained by the lungs, and clearance from the lungs occurs when the inhaled material is sequestered by alveolar cells or removed via the lymphatic vessels to local lymph nodes. Some inhaled material (about 5%) is absorbed by the mucosa and passes to the gastro-intestinal tract. In general, however it is thought that the contribution of inhaled lead to body burdens is relatively small (Lawther, 1972). 

---